Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

421281

registered interest
date	14/10/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Amyloidosis
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government what progress is being made by University College London in association with the National Amyloidosis Centre and GlaxoSmithKline to develop a combined small molecule antibody treatment for amyloidosis.
tabling member printed	Lord Willis of Knaresborough
uin	HL2652
answer	answer is ministerial correction date of answer 22/10/2015 answer text <p>Results in the first 15 patients with systemic amyloidosis treated with a combination of CPHPC and anti-SAP antibody have been published in the <em>New England Journal of Medicine</em>. The phase I study is funded by GlaxoSmithKline (GSK) and the research team includes researchers at University College London (UCL) and the National Amyloidosis Centre (NAC).</p><br /><p>The National Institute for Health Research Clinical Research Network (CRN) provides support to help the life sciences industry delivery high quality commercial contract clinical research in the national health service. If a phase II trial is developed, the CRN will work with GSK, the NAC and UCL as appropriate, to deliver the trial.</p> answering member printed Lord Prior of Brampton grouped question UIN HL2653 question first answered 22/10/2015 12:13:17 answering member 127 label Biography information for Lord Prior of Brampton
tabling member	4151 label Biography information for Lord Willis of Knaresborough

106181

registered interest
date	04/11/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Tobacco
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government what is the legal status in United Kingdom law of the Framework Convention on Tobacco Control Protocol and the Local Government Declaration on Tobacco Control.
tabling member printed	Lord Palmer
uin	HL2652
answer	answer is ministerial correction date of answer 18/11/2014 answer text <p>The World Health Organization Framework Convention on Tobacco Control (FCTC) is an international treaty that the United Kingdom signed on 16 June 2003, ratified on 16 December 2004 and which entered into force for the UK on 16 March 2005. The UK has therefore consented to be bound under international law by the rights and obligations set out in the FCTC. More information on the FCTC, including the text of the treaty is at on the web at:</p><p> </p><p> </p><p> </p><p>www.who.int/fctc<br> <br> The Local Government Declaration on Tobacco Control is an initiative of the Smokefree Action Coalition. Local councils are invited to voluntarily sign the Declaration, as “a statement of a council’s commitment to ensure tobacco control is part of mainstream public health work and commits councils to taking comprehensive action to address the harm from smoking”. More information on the Declaration is on the web at:</p><p> </p><p> </p><p> </p><p>www.smokefreeaction.org.uk/declaration</p><p> </p> answering member printed Earl Howe question first answered 18/11/2014 12:41:51 answering member 2000 label Biography information for Earl Howe
tabling member	3192 label Biography information for Lord Palmer